Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2560 of 5804
-
Mindfulness may shield aging brains from Alzheimer's
Prevention Recruiting nowThe primary objective of the proposed research is to investigate the promise and underlying mechanisms of mindfulness training as a preventative lifestyle intervention to enhance cognitive health in Latino older adults, thereby mitigating risk of Alzheimer's Disease (AD) in a pop…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Prevention
Last updated Jun 27, 2026 12:32 UTC
-
VR headsets could slash opioid use after surgery
Symptom relief Recruiting nowThis clinical trial aims to evaluate the efficacy of virtual reality (VR) as an adjunctive therapeutic method to reduce opioid consumption during the postoperative period of cardiac and thoracic surgeries. Conducted at InCor/HCFMUSP, this single-center, prospective, randomized tr…
Phase: NA • Sponsor: Filomena R B G Galas • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Your voice may tell if You're using opioids – new study says yes!
Knowledge-focused CompletedThis study explored whether changes in a person's voice could help identify opioid use in patients with opioid use disorder (OUD). Current methods for determining whether a patient is intoxicated or in withdrawal often rely on self-reporting and clinical judgment, which can be su…
Sponsor: Tenvos Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Vulvar cancer breakthrough: one test could spare women unnecessary surgery
Knowledge-focused Recruiting nowThis study is being done to answer the following question: Are there types of early-stage vulvar cancer that require either less or more treatment than the usual approach?
Phase: NA • Sponsor: Canadian Cancer Trials Group • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC
-
New laser could keep melasma from coming back
Disease control OngoingMelasma is a frequently acquired hyperpigmentary disorder affecting up to 30% of child-bearing women in some populations. Melasma is still often called chloasma or the pregnancy mask and is considered as the main consequence of female hormone stimulation on a predisposed genetic …
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New insulin combo aims to improve daily blood sugar control in type 2 diabetes
Disease control Recruiting nowThis study is an open-label, 1:1 randomized, active-controlled, 2-arm, 20-week treatment duration, parallel-group, multicenter, phase IV study to evaluate the effect of iGlarLixi versus Gla-100 on glycemic control measured as TIR from CGM device in Chinese insulin naïve patients …
Phase: PHASE4 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Johns hopkins launches study to uncover hidden cause of right heart failure
Knowledge-focused Recruiting nowRight ventricular (RV) failure is recognized to worsen patient outcomes in the setting of heart failure with reduced ejection fraction (HFrEF)-related pulmonary hypertension (PH), yet the investigators fall short in trying to identify and treat it. The current proposal will (1) d…
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
Could an allergy pill ease Parkinson's? new trial launches
Symptom relief Recruiting nowParkinson's disease (PD) is a chronic, progressive neurological disorder characterized by both motor and non-motor symptoms. PD is the second most common neurodegenerative disorder after Alzheimer's disease and the most common movement disorder. PD has age-related pathology; it i…
Phase: PHASE2, PHASE3 • Sponsor: Tanta University • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
New drug RAY121 tested for Long-Term control of autoimmune diseases
Disease control ENROLLING_BY_INVITATIONThis is a long-term extension trial of RAY121 in patients with immunological diseases such as antiphospholipid syndrome (APS), bullous pemphigoid (BP), Behçet's Syndrome (BS), dermatomyositis (DM), immune-mediated necrotizing myopathy (IMNM) and immune thrombocytopenia (ITP).
Phase: PHASE1 • Sponsor: Chugai Pharmaceutical • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
VR therapy shows promise for Schizophrenia's 'Negative' symptoms
Symptom relief CompletedThe primary goal of this pilot study is to examine the feasibility and acceptability of a new Virtual Reality-based intervention against negative symptoms in schizophrenia spectrum disorders (SSD). The main questions it aims to answer are: 1. Is Virtual Reality-based therapy a …
Phase: NA • Sponsor: Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Can simple reminders and training boost HPV shots in rural teens?
Prevention Recruiting nowThere are three main objectives of the protocol. First, we will evaluate the added clinical- and cost- effectiveness of parent-targeted motivational aids (reminder/recall and phone-based MI) alone and when combined with community-targeted healthcare access assistance beyond the e…
Phase: NA • Sponsor: University of Florida • Aim: Prevention
Last updated Jun 26, 2026 14:42 UTC
-
New anxiety drug shows promise in early trial
Symptom relief CompletedThis is a randomized, double-blind, placebo-controlled study to evaluate the safety and tolerability of ENX-102 and determine a dose-response for the effects of ENX-102 in patients with GAD
Phase: PHASE2 • Sponsor: Engrail Therapeutics INC • Aim: Symptom relief
Last updated Jun 26, 2026 18:21 UTC
-
New pill KQB198 tested for tough blood cancers
Disease control OngoingThe goal of this clinical trial is to learn if KQB198 works to treat advanced hematologic malignancies in adults. It will also learn about the safety of KQB198. The main questions it aims to answer are: * What is the safe dose of KQB198 by itself or in combination with other ant…
Phase: PHASE1 • Sponsor: Kumquat Biosciences Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New study tests Self-Management program for arthritis patients
Symptom relief Recruiting nowBackground: In patients newly diagnosed with inflammatory arthritis, a self-management intervention is anticipated to enhance self-management skills, thereby improving patient function, well-being, and survival. The primary objective of the trial is to investigate the short-term…
Phase: NA • Sponsor: Glostrup University Hospital, Copenhagen • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
New test aims to predict cancer return after bone marrow transplant
Knowledge-focused Recruiting nowPresently, multiparameter flow cytometry (MFC) and polymerase chain reaction (PCR) have been used for disease load, including measurable residual disease (MRD), monitoring in patients with myelodysplastic syndrome (MDS). MFC is the most commonly method for disease load evaluation…
Sponsor: Peking University People's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Spinal fluid chemo cocktail targets tough brain cancer spread
Disease control Recruiting nowThis is a prospective, single-arm, phase Ia clinical study, which was designed to evaluate the efficacy and safety of Pemetrexed Combined With Bevacizumab Intrathecal Injection in Patients With Leptomeningeal Metastases in NSCLC.
Phase: PHASE1 • Sponsor: Shanghai Chest Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Shocking recovery: electrical zaps may help stroke survivors regain arm strength
Symptom relief Recruiting nowStroke is a leading cause of long-term disability and often results in impaired upper extremity function and reduced aerobic capacity. Improving both cardiovascular and function is an important goal in stroke rehabilitation. This study aims to compare the effects of conventional…
Phase: NA • Sponsor: Ankara City Hospital Bilkent • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Could a cancer drug tame lupus in kids?
Disease control Recruiting nowThe goal of this clinical trial is to learn if blinatumomab works to treat refractory or active systemic lupus erythematosus (SLE) in children and adults. It will also learn about the safety of blinatumomab. The main questions it aims to answer are: Does blinatumomab improve sym…
Phase: PHASE1 • Sponsor: Mao Jianhua • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Toddlers with CP race ahead in joyful movement study
Symptom relief ENROLLING_BY_INVITATIONThe aim of this project is to implement and evaluate the effects of a mobility-focused training program, including the use of running frames, on gross motor function and physical activity levels in children aged 2-5 years with cerebral palsy. The hypothesis is that these children…
Phase: NA • Sponsor: Karolinska Institutet • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New telehealth program aims to help stroke survivors shed pounds
Disease control Recruiting nowInvestigators will conduct a randomized controlled trial (RCT) to assess intervention efficacy of telehealth delivery of the GLB-CVA (tGLB-CVA) compared to a 6-month wait-list control (WLC) in partnership with a diverse group of patient partners and peer mentors.
Phase: NA • Sponsor: Baylor Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC